Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Rx Guaifenesin Ban Justified By Compliance Policy Guide – Adams Labs

Dec 23 2002

• By The Tan Sheet

Related Content

Adams Labs Mucinex Marketing Strategy Targeting Healthcare Professionals

Jul 22 2002

FDA Guaifenesin Crackdown Based On Adams Labs NDA “Improper” – Petition

Nov 18 2002

Adams Mucinex Approval Spurs FDA Crackdown On Guaifenesin Products

Oct 21 2002

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window